Prescription drugs treat conditions and improve patient health. But when drug prices are too high, access to medicines becomes out of reach for far too many patients.
According to FDA estimates, generics are 80%-85% less expensive than their brand-name drug equivalents. Competition and a patient-centered orientation are what make generics and biosimilars the solution that helps people live their lives, their way. The Association for Accessible Medicines and its members give millions of Americans what they need to live healthier, more productive lives.
Patients win when market-based competition from FDA-approved generics and biosimilars deliver savings at the pharmacy counter. That’s why AAM is calling on Congress to take meaningful action to lower prescription drug costs.
Take action now via our current advocacy campaigns.
Visit our blog to keep up with the range of activities AAM conducts to educate state and federal lawmakers, influencers and the public about the value proposition of generic and biosimilar drugs.
Discover the stories we’re collecting about how U.S. patients are saving money with safe, effective, FDA-approved generic drugs.